Sign up to save your podcasts
Or
Share Bjarne Kveim Lie - The status at growth stage, Eur 5B committed, 140 investments, Growth > FCF, Dr Alban and the asymmetric risk-reward ratio
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bjarne Kveim Lie - The status at growth stage, Eur 5B committed, 140 investments, Growth > FCF, Dr Alban and the asymmetric risk-reward ratio
Bjarne Kveim Lie - Managing Partner and Chief Investment Officer at Verdane.
Verdane invests in technology companies with equity tickets between 8 and 150m Euro, they have Eur 5B of committed capital and over 140 investments since 2003. They have a flexible mandate and can make both minority and majority investments. In addition to making individual investments they also act as a solution provider for GPs that seek liquidity and have completed over 50 so called ‘secondary directs’ over the years.
They have been named Best European PE Growth Fund all the years between 2019 and 2023 and Best European mid-market PE fund in 2022.
During this episode we discuss about the status of the growth stage as an asset class, the learnings from investing for over 20 years and the fun parallel between investing with an asymmetric risk reward ratio and Dr Alban. It’s my life!
View all episodes
By Calin Fabri | Entrepreneur | AdvisorBjarne Kveim Lie - Managing Partner and Chief Investment Officer at Verdane.
Verdane invests in technology companies with equity tickets between 8 and 150m Euro, they have Eur 5B of committed capital and over 140 investments since 2003. They have a flexible mandate and can make both minority and majority investments. In addition to making individual investments they also act as a solution provider for GPs that seek liquidity and have completed over 50 so called ‘secondary directs’ over the years.
They have been named Best European PE Growth Fund all the years between 2019 and 2023 and Best European mid-market PE fund in 2022.
During this episode we discuss about the status of the growth stage as an asset class, the learnings from investing for over 20 years and the fun parallel between investing with an asymmetric risk reward ratio and Dr Alban. It’s my life!
More shows like Venture Europe: Entrepreneurship | Technology | Venture Capital | Eu/Acc
View all
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
527 Listeners
The Daily
112,414 Listeners
Wild Business Growth
176 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,816 Listeners
Huberman Lab
29,186 Listeners
Unsupervised Learning
51 Listeners